Adicet Bio (ACET) Depreciation & Amortization (CF) (2017 - 2026)

Adicet Bio's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 23.53% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $6.0 million (down 8.94% YoY), while the FY2025 annual figure was $6.4 million, down 1.35% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $1.3 million, down from $1.5 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $1.7 million in Q1 2025, with the low at $400000.0 in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $1.6 million (2023), against an average of $1.3 million.
• The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) jumped 275.0% in 2023, then decreased 23.53% in 2026.
• Adicet Bio's Depreciation & Amortization (CF) stood at $1.1 million in 2022, then soared by 53.73% to $1.7 million in 2023, then retreated by 1.36% to $1.7 million in 2024, then declined by 11.21% to $1.5 million in 2025, then decreased by 12.22% to $1.3 million in 2026.
• Business Quant data shows ACET's Depreciation & Amortization (CF) at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $1.6 million in Q3 2025.